Home › Topics › Refractive Error and Myopia
Refractive Error and Myopia
GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal
SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch
Uncorrected refractive error — myopia, hyperopia, astigmatism and presbyopia — is the single largest cause of vision impairment globally, affecting an estimated 157 million people with distance vision impairment and 510 million with near vision impairment, virtually all of it correctable with a pair of spectacles costing a few dollars, making it the starkest example in medicine of an entirely solved clinical problem that remains unsolved as a delivery problem (WHO). Superimposed on this is a genuine epidemiological emergency: myopia prevalence in children has risen dramatically across East and Southeast Asia, exceeding 80-90% in some urban cohorts by the end of secondary schooling, driven by intensive near work and — critically — reduced time outdoors, with high myopia carrying lifelong elevated risks of retinal detachment, myopic maculopathy, glaucoma and cataract; evidence-based control measures now include increased outdoor time, low-dose atropine 0.01-0.05%, orthokeratology and specialised defocus spectacle lenses.
Key messages
The largest single cause of vision impairment globally — and the cheapest to fix
Uncorrected refractive error causes distance vision impairment in an estimated 157 million people and near vision impairment in around 510 million — the largest single contributor to global vision impairment. Virtually all of it is correctable with a pair of spectacles. It is the clearest example in medicine of a fully solved clinical problem that remains an unsolved delivery problem: the barriers are availability of refraction services, cost, distance and awareness, not scientific uncertainty.
The childhood myopia epidemic is real and geographically concentrated
Myopia prevalence among children and young adults has risen dramatically over recent decades, most steeply in East and Southeast Asia, where prevalence in urban cohorts finishing secondary school exceeds 80-90% in several studies, with high myopia (worse than -6.00D) affecting a substantial minority. Prevalence is rising more slowly but measurably in Europe, North America and elsewhere. Global projections suggest around half the world population could be myopic by 2050. This is a change in environment, not genetics — genetics cannot change over two generations.
High myopia is not just a spectacle prescription — it is a lifelong disease risk
The reason the epidemic matters clinically: axial elongation of the globe carries permanent, dose-dependent risks that persist regardless of optical or surgical correction. High myopia substantially increases lifetime risk of: retinal detachment; myopic macular degeneration (a leading cause of irreversible blindness in East Asia); open-angle glaucoma; and earlier cataract. Correcting the refractive error with spectacles, contact lenses or laser surgery corrects the FOCUS but does not reduce these structural risks. This is why myopia CONTROL in childhood — slowing axial elongation — is a fundamentally different goal from myopia correction.
Outdoor time is the best-supported preventive intervention
Time spent outdoors in daylight reduces the incidence of new myopia in children — supported by cluster-randomised school-based trials (notably in Guangzhou and Taiwan) and consistent cohort data. Around two hours per day is the commonly cited target. The mechanism is thought to involve high ambient light intensity stimulating retinal dopamine release, which inhibits axial elongation, rather than simply displacing near work. Importantly, outdoor time appears more effective at PREVENTING myopia onset than at slowing progression once myopia has developed — making it a public health and school-policy intervention as much as a clinical one.
Low-dose atropine, orthokeratology and defocus lenses slow progression
Established myopia control options: low-dose atropine eye drops (0.01% to 0.05% — higher concentrations more effective but with more photophobia, near blur and rebound on cessation; 0.05% currently has the best efficacy-tolerability balance in the ATOM and LAMP studies); orthokeratology (overnight rigid contact lenses reshaping the cornea — effective but carries a real risk of microbial keratitis requiring rigorous hygiene); soft multifocal or peripheral-defocus contact lenses (MiSight); and defocus incorporated spectacle lenses (DIMS, HAL/lenslet designs) which slow axial elongation by around 50-60% in trials. These reduce progression; none stops it.
Presbyopia — 510 million with uncorrected near vision impairment
Presbyopia — the age-related loss of accommodative amplitude from lens stiffening, universally beginning around age 40-45 — is not a disease but its uncorrected form is the single largest cause of near vision impairment worldwide. Its economic consequences are substantial and under-appreciated: loss of near vision removes the ability to do close work (tailoring, weaving, sorting, fine assembly, reading, phone use) precisely in the most economically productive years, and studies of ready-made reading spectacle provision in tea pickers and textile workers have demonstrated measurable productivity and income gains. Simple ready-made reading spectacles resolve most cases at very low cost.
Key statistics
157M / 510M
people with distance / near vision impairment from uncorrected refractive error
WHO World Report on Vision~2 hours/day
outdoor time associated with reduced myopia incidence in school-based trials
JAMA/Ophthalmology0.05% atropine
best efficacy-tolerability balance for myopia control in the LAMP study
LAMP/OphthalmologyMyopia control interventions — approximate reduction in axial elongation
Glossary of key terms
Latest GMJ coverage
Articles will appear here as the archive grows.
Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery
Knowledge hub: guidelines, conventions and reports
Organizations working in migration and health
Related health topics
Eye care and visionCataract and IOL refractive outcomesGlaucoma risk in high myopiaSchool vision screeningScreen use and near workPresbyopia and ageing
About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team

